The Oncology Marketing Fellowship at Seattle Genetics offers a unique opportunity to pair one’s PharmD clinical training with hands-on commercial experience in biotechnology. The 1-year post-doctoral program is meant to serve as a strong foundation for a career within the pharmaceutical industry.
The fellow will assist and lead a variety of projects within the Marketing group while interacting with personnel from Sales, Market Planning, Managed Markets as well as key cross-functional groups including Medical Affairs, Regulatory Affairs, and Clinical Development. The fellow will also have opportunities to participate in strategic marketing initiatives, including the development of brand and tactical plans.
The fellow will support ADCETRIS® (brentuximab vedotin), an antibody-drug conjugate (ADC) directed to the CD30 surface antigen on cells using Seattle Genetics' proprietary ADC technology. The fellow will also support Seattle Genetics’ pipeline programs, including late-stage agents enfortumab vedotin and tucatinib.
Leverage clinical insights to develop impactful marketing tools in collaboration with internal stakeholders and agency partners
Manage the development and execution of select branded and unbranded promotional materials
Coordinate key logistical activities, notably those related to the promotional review committee, promotional material fulfillment, and national congress planning
Summarize key insights from emerging clinical data in the oncology space to inform projects and initiatives within the commercial organization
Manage advertising agencies and other commercial vendors
Develop and deliver presentations as needed to the marketing team and other internal groups
Participate in commercial strategy planning and brand plan development
Travel may include, but is not limited to, attendance at key sales and marketing meetings, as well as attendance at annual ASCO, ASH, and ASHP meetings
A Doctor of Pharmacy degree from an ACPE accredited institution
Relevant Internship or Clerkship experience
Oncology experience is a plus
Strong interpersonal communication skills
Evidence of good communication, analytical, planning and organizational skills
Basic knowledge of the pharmaceutical industry including Product Development, Manufacturing, Regulatory, Medical Affairs, and Commercial operations
Possess good communication skills, including oral, written, and presentation
Ability to thrive in a fast-paced, dynamic environment
Must be willing to travel
Seattle Genetics is an equal opportunity employer. All qualified applications will receive consideration for employment without regard to race, age, gender identity, sexual orientation, color, religion, sex, marital status, national origin, protected veteran status, disability status, or any other status protected by federal, state, or local law.
Application deadline is Monday, November 27th, 2019.
Letters of Recommendation are not required with application and are only required upon request.
Internal Number: 2019-629
About Seattle Genetics
Seattle Genetics is an emerging multi-product, global biotechnology company that develops and commercializes transformative therapies targeting cancer to make a meaningful difference in people’s lives. ADCETRIS® (brentuximab vedotin) uses the company’s industry-leading antibody-drug conjugate (ADC) technology and is approved for the treatment of multiple CD30-expressing lymphomas.
Beyond ADCETRIS, the company has established a pipeline of novel targeted therapies at various stages of clinical testing, including three in ongoing or planned pivotal trials for solid tumors. Enfortumab vedotin for metastatic urothelial cancer and tisotumab vedotin for metastatic cervical cancer use our proprietary ADC technology. Tucatinib, a small molecule tyrosine kinase inhibitor, is in a pivotal trial for HER2-positive metastatic breast cancer. In addition, we are leveraging our expertise in empowered antibodies to build a portfolio of proprietary immuno-oncology agents in clinical trials targeting hematologic malignancies and solid tumors.